Fig. 1From: Clearance of senescent cells with ABT-263 improves biological functions of synovial mesenchymal stem cells from osteoarthritis patientsScheme of the experiments. Synovial mesenchymal stem cells (MSCs) from osteoarthritis (OA) patients were treated with 0.1% dimethyl sulfoxide (DMSO) or 20 µM ABT-263 in DMSO for 24 h. After the treatment, the cells were expanded for another 6 days and used for the experiments. Annexin V/propidium iodide (PI) staining and cleaved caspase-3 immunostaining were performed immediately after the treatment for 24 and 6 h, respectivelyBack to article page